With imeglimin , the A@C level decreased by @ % in @ % of subjects vs. @ % with placebo ( P < @ ) , and @ % of subjects receiving imeglimin achieved a decrease in A@C level of @ % compared with subjects receiving placebo ( @ % ) ( P = @ ) .